/People

Alek Safarian

Investor

CEO at ALSA Ventures

New York, New York, United States

Find your path to Alek

Sign up to see every warm intro you have to Alek

  • Paths you didn't know you had: your email and LinkedIn already hold routes to Alek. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

About

A pharmacist with over thirty years in drug development, Alek worked in regulatory and clinical research roles across the Asia-Pacific and founded the Sydney-based CRO Novotech. He holds a BPharm and MBA from the University of Sydney.

Contact· published on Alek's own website

Colleagues at ALSA Ventures

Network33

▶21 more connections

Barbara SchilbergBiao HeCharline GauthierClay WhiteheadCobih ObihCody AndersonCorey CentenDarius CheungDavis OkothDelia FlanaganDmytro DvurechenskyiDoug WilstermanEduardo ChadesEmily WangErik SchmidtEugene WeiFaisal AloufiiFrancesca BertocchiGilad NovickGladys NunezTerence Leahy

Investors connected to Alek in public investor directories — a warm-intro map.

Frequently asked questions

Who is Alek Safarian?
A pharmacist with over thirty years in drug development, Alek worked in regulatory and clinical research roles across the Asia-Pacific and founded the Sydney-based CRO Novotech. He holds a BPharm and MBA from the University of Sydney.
Where does Alek Safarian work?
Alek Safarian is CEO at ALSA Ventures.

Founder mafias

About this profile. Compiled from public sources — ALSA Ventures's own website and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights